newsfilter
← Latest News
GlobeNewswire·

LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026

SAN DIEGO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (NASDAQ:LENZ), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmologic solution) 1.44%, the first and only